Hyperfine, Inc.: Business Overview, Financials & Competitive Analysis
Hyperfine, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). High-risk medical device innovator with transformative portable MRI technology facing execution and commercialization challenges at a critical scaling inflection point. Hyperfine demonstrates strong clinical validation and recent regulatory expansion into India, with record Q4 placements and next-generation product launches. However, the company remains pre-profitability with negative EBITDA of $38.74M and.
What is Hyperfine, Inc.'s industry? Hyperfine, Inc. (hyperfine.io) operates in Medical Devices & Healthcare Equipment Manufacturing. AskCyborg classifies Hyperfine, Inc. under Medical Devices & Healthcare Equipment Manufacturing in its company registry.
Hyperfine is a health technology company producing and commercializing the Swoop Portable MR Imaging System, which generates MRI images at lower magnetic field strength than conventional MRI scanners. Recent clinical ...
Cyborg Score thesis
High-risk medical device innovator with transformative portable MRI technology facing execution and commercialization challenges...
Read the full analyst-debate transcript →Get the Latest Hyperfine, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeHyperfine, Inc. Overview
Pro stress-test →Hyperfine is a health technology company producing and commercializing the Swoop Portable MR Imaging System, which generates MRI images at lower magnetic field strength than conventional MRI scanners. Recent clinical validation through the NEURO PMR study showed the portable Swoop MRI achieved 92% diagnostic concordance with standard MRI and demonstrated superior patient experience in outpatient neurology clinics.
Strategic Profile
Pro stress-test →The company is positioned for rapid clinical adoption and global expansion, with the Swoop system expected to achieve outsized revenue growth, strong recurring high-margin revenue, and substantial operating margin improvements. Hyperfine recently obtained regulatory approval from India's Central Drugs Standard Control Organization in December 2025 and is planning commercial launches in India and other international markets.
Competitive Landscape
Pro stress-test →Hyperfine competes in the medical imaging market, targeting displacement of traditional fixed MRI systems with its portable ultra-low-field alternative that offers accessibility and cost advantages. Primary competition comes from incumbent MRI manufacturers (GE Healthcare, Siemens, Philips) with established installed bases and conventional high-field systems, plus emerging portable/point-of-care imaging competitors.
Industry Context
Hyperfine, Inc. operates in Medical Devices & Healthcare Equipment Manufacturing.
Key facts
Founded: 2014 · Headquarters: Guilford, Connecticut, US · Employees: 111 · Revenue: $0.01B · Market cap: $0.11B